A University of Colorado Cancer Center clinical trial led by Elena Shagisultanova, MD, helped Colorado mother of five Erica Greenwood go from a terminal inflammatory breast cancer diagnosis to no evidence of disease through a three-drug combination targeting parallel tumor pathways.